Abstract
The majority of patients with multiple sclerosis (MS) suffer from lower urinary tract symptoms and sexual dysfunction at some stage of the disease. This has a negative impact on the quality of life of patients as well as causing concern to caregivers and family. Neurologists can now treat most of these symptoms by a number of pharmacological and non-pharmacological methods. This review presents the neuroanatomy, neurophysiology, neuropharmacology and pathophysiology of the urinary bladder and sexual organs, and the biological mechanisms underlying urogenital dysfunction in MS patients. Current treatment options for urinary and sexual dysfunction are reviewed. As most urogenital symptoms of MS can now be treated by conservative means, expert urological or gynaecological consultation should be requested only if more aggressive diagnostic or therapeutic measures are needed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Additional information
Received: 24 July 2001, Accepted: 25 July 2001
Rights and permissions
About this article
Cite this article
Fernández, O. Mechanisms and current treatments of urogenital dysfunction in multiple sclerosis. J Neurol 249, 1–8 (2002). https://doi.org/10.1007/PL00007835
Issue Date:
DOI: https://doi.org/10.1007/PL00007835